Table of Content

1 Neurofibromatosis Type 1 Market Overview
1.1 Product Overview and Scope of Neurofibromatosis Type 1
1.2 Neurofibromatosis Type 1 Segment by Type
1.2.1 Global Neurofibromatosis Type 1 Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 10 mg
1.2.3 25 mg
1.3 Neurofibromatosis Type 1 Segment by Application
1.3.1 Neurofibromatosis Type 1 Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Neurofibromatosis Type 1 Market Size Estimates and Forecasts
1.4.1 Global Neurofibromatosis Type 1 Revenue 2016-2027
1.4.2 Global Neurofibromatosis Type 1 Sales 2016-2027
1.4.3 Neurofibromatosis Type 1 Market Size by Region: 2016 Versus 2021 Versus 2027

2 Neurofibromatosis Type 1 Market Competition by Manufacturers
2.1 Global Neurofibromatosis Type 1 Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neurofibromatosis Type 1 Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neurofibromatosis Type 1 Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neurofibromatosis Type 1 Manufacturing Sites, Area Served, Product Type
2.5 Neurofibromatosis Type 1 Market Competitive Situation and Trends
2.5.1 Neurofibromatosis Type 1 Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neurofibromatosis Type 1 Players Market Share by Revenue
2.5.3 Global Neurofibromatosis Type 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neurofibromatosis Type 1 Retrospective Market Scenario by Region
3.1 Global Neurofibromatosis Type 1 Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Neurofibromatosis Type 1 Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Neurofibromatosis Type 1 Market Facts & Figures by Country
3.3.1 North America Neurofibromatosis Type 1 Sales by Country
3.3.2 North America Neurofibromatosis Type 1 Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neurofibromatosis Type 1 Market Facts & Figures by Country
3.4.1 Europe Neurofibromatosis Type 1 Sales by Country
3.4.2 Europe Neurofibromatosis Type 1 Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neurofibromatosis Type 1 Market Facts & Figures by Region
3.5.1 Asia Pacific Neurofibromatosis Type 1 Sales by Region
3.5.2 Asia Pacific Neurofibromatosis Type 1 Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Neurofibromatosis Type 1 Market Facts & Figures by Country
3.6.1 Latin America Neurofibromatosis Type 1 Sales by Country
3.6.2 Latin America Neurofibromatosis Type 1 Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neurofibromatosis Type 1 Market Facts & Figures by Country
3.7.1 Middle East and Africa Neurofibromatosis Type 1 Sales by Country
3.7.2 Middle East and Africa Neurofibromatosis Type 1 Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Neurofibromatosis Type 1 Historic Market Analysis by Type
4.1 Global Neurofibromatosis Type 1 Sales Market Share by Type (2016-2021)
4.2 Global Neurofibromatosis Type 1 Revenue Market Share by Type (2016-2021)
4.3 Global Neurofibromatosis Type 1 Price by Type (2016-2021)

5 Global Neurofibromatosis Type 1 Historic Market Analysis by Application
5.1 Global Neurofibromatosis Type 1 Sales Market Share by Application (2016-2021)
5.2 Global Neurofibromatosis Type 1 Revenue Market Share by Application (2016-2021)
5.3 Global Neurofibromatosis Type 1 Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Neurofibromatosis Type 1 Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Neurofibromatosis Type 1 Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates

7 Neurofibromatosis Type 1 Manufacturing Cost Analysis
7.1 Neurofibromatosis Type 1 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neurofibromatosis Type 1
7.4 Neurofibromatosis Type 1 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neurofibromatosis Type 1 Distributors List
8.3 Neurofibromatosis Type 1 Customers

9 Neurofibromatosis Type 1 Market Dynamics
9.1 Neurofibromatosis Type 1 Industry Trends
9.2 Neurofibromatosis Type 1 Growth Drivers
9.3 Neurofibromatosis Type 1 Market Challenges
9.4 Neurofibromatosis Type 1 Market Restraints

10 Global Market Forecast
10.1 Neurofibromatosis Type 1 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neurofibromatosis Type 1 by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neurofibromatosis Type 1 by Type (2022-2027)
10.2 Neurofibromatosis Type 1 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neurofibromatosis Type 1 by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neurofibromatosis Type 1 by Application (2022-2027)
10.3 Neurofibromatosis Type 1 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neurofibromatosis Type 1 by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neurofibromatosis Type 1 by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurofibromatosis Type 1 Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Neurofibromatosis Type 1 Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Neurofibromatosis Type 1 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Neurofibromatosis Type 1 Covered in This Study
Table 5. Global Neurofibromatosis Type 1 Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Neurofibromatosis Type 1 Sales Share by Manufacturers (2016-2021)
Table 7. Global Neurofibromatosis Type 1 Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Neurofibromatosis Type 1 Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Neurofibromatosis Type 1 Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Neurofibromatosis Type 1 Manufacturing Sites and Area Served
Table 11. Manufacturers Neurofibromatosis Type 1 Product Type
Table 12. Global Neurofibromatosis Type 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neurofibromatosis Type 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurofibromatosis Type 1 as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Neurofibromatosis Type 1 Sales by Region (2016-2021) & (K Units)
Table 16. Global Neurofibromatosis Type 1 Sales Market Share by Region (2016-2021)
Table 17. Global Neurofibromatosis Type 1 Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Neurofibromatosis Type 1 Sales by Country (2016-2021) & (K Units)
Table 19. North America Neurofibromatosis Type 1 Sales Market Share by Country (2016-2021)
Table 20. North America Neurofibromatosis Type 1 Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Neurofibromatosis Type 1 Revenue Market Share by Country (2016-2021)
Table 22. Europe Neurofibromatosis Type 1 Sales by Country (2016-2021) & (K Units)
Table 23. Europe Neurofibromatosis Type 1 Sales Market Share by Country (2016-2021)
Table 24. Europe Neurofibromatosis Type 1 Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Neurofibromatosis Type 1 Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Neurofibromatosis Type 1 Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Neurofibromatosis Type 1 Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Neurofibromatosis Type 1 Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Neurofibromatosis Type 1 Revenue Market Share by Region (2016-2021)
Table 30. Latin America Neurofibromatosis Type 1 Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Neurofibromatosis Type 1 Sales Market Share by Country (2016-2021)
Table 32. Latin America Neurofibromatosis Type 1 Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Neurofibromatosis Type 1 Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Neurofibromatosis Type 1 Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Neurofibromatosis Type 1 Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Neurofibromatosis Type 1 Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Neurofibromatosis Type 1 Revenue Market Share by Country (2016-2021)
Table 38. Global Neurofibromatosis Type 1 Sales (K Units) by Type (2016-2021)
Table 39. Global Neurofibromatosis Type 1 Sales Market Share by Type (2016-2021)
Table 40. Global Neurofibromatosis Type 1 Revenue (Million US$) by Type (2016-2021)
Table 41. Global Neurofibromatosis Type 1 Revenue Share by Type (2016-2021)
Table 42. Global Neurofibromatosis Type 1 Price (US$/Unit) by Type (2016-2021)
Table 43. Global Neurofibromatosis Type 1 Sales (K Units) by Application (2016-2021)
Table 44. Global Neurofibromatosis Type 1 Sales Market Share by Application (2016-2021)
Table 45. Global Neurofibromatosis Type 1 Revenue (Million US$) by Application (2016-2021)
Table 46. Global Neurofibromatosis Type 1 Revenue Share by Application (2016-2021)
Table 47. Global Neurofibromatosis Type 1 Price (US$/Unit) by Application (2016-2021)
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Neurofibromatosis Type 1 Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. AstraZeneca Neurofibromatosis Type 1 Product
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Neurofibromatosis Type 1 Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Merck Neurofibromatosis Type 1 Product
Table 57. Merck Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Neurofibromatosis Type 1 Distributors List
Table 61. Neurofibromatosis Type 1 Customers List
Table 62. Neurofibromatosis Type 1 Market Trends
Table 63. Neurofibromatosis Type 1 Growth Drivers
Table 64. Neurofibromatosis Type 1 Market Restraints
Table 65. Global Neurofibromatosis Type 1 Sales Forecast by Type (2022-2027) & (K Units)
Table 66. Global Neurofibromatosis Type 1 Sales Market Share Forecast by Type (2022-2027)
Table 67. Global Neurofibromatosis Type 1 Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 68. Global Neurofibromatosis Type 1 Revenue Market Share Forecast by Type (2022-2027)
Table 69. Global Neurofibromatosis Type 1 Sales Forecast by Application (2022-2027) & (K Units)
Table 70. Global Neurofibromatosis Type 1 Sales Market Share Forecast by Application (2022-2027)
Table 71. Global Neurofibromatosis Type 1 Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 72. Global Neurofibromatosis Type 1 Revenue Market Share Forecast by Application (2022-2027)
Table 73. Global Neurofibromatosis Type 1 Sales Forecast by Region (2022-2027) & (K Units)
Table 74. Global Neurofibromatosis Type 1 Sales Market Share Forecast by Region (2022-2027)
Table 75. Global Neurofibromatosis Type 1 Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 76. Global Neurofibromatosis Type 1 Revenue Market Share Forecast by Region (2022-2027)
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neurofibromatosis Type 1
Figure 2. Global Neurofibromatosis Type 1 Market Share by Type in 2020 & 2027
Figure 3. 10 mg Product Picture
Figure 4. 25 mg Product Picture
Figure 5. Global Neurofibromatosis Type 1 Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Neurofibromatosis Type 1 Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Neurofibromatosis Type 1 Market Size 2016-2027 (US$ Million)
Figure 11. Global Neurofibromatosis Type 1 Sales 2016-2027 (K Units)
Figure 12. Global Neurofibromatosis Type 1 Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Neurofibromatosis Type 1 Sales Share by Manufacturers in 2020
Figure 14. Global Neurofibromatosis Type 1 Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Neurofibromatosis Type 1 Players: Market Share by Revenue in 2020
Figure 16. Neurofibromatosis Type 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Neurofibromatosis Type 1 Sales Market Share by Region (2016-2021)
Figure 18. Global Neurofibromatosis Type 1 Sales Market Share by Region in 2020
Figure 19. Global Neurofibromatosis Type 1 Revenue Market Share by Region (2016-2021)
Figure 20. Global Neurofibromatosis Type 1 Revenue Market Share by Region in 2020
Figure 21. U.S. Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Neurofibromatosis Type 1 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Neurofibromatosis Type 1 by Type (2016-2021)
Figure 46. Sales Market Share of Neurofibromatosis Type 1 by Application (2016-2021)
Figure 47. Sales Market Share of Neurofibromatosis Type 1 by Application in 2020
Figure 48. Revenue Share of Neurofibromatosis Type 1 by Application (2016-2021)
Figure 49. Revenue Share of Neurofibromatosis Type 1 by Application in 2020
Figure 50. Manufacturing Cost Structure of Neurofibromatosis Type 1
Figure 51. Manufacturing Process Analysis of Neurofibromatosis Type 1
Figure 52. Neurofibromatosis Type 1 Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed